Mediterranean Fertility Center & Genetic Services

The Mediterranean Fertility Center & Genetic Services (MFCGS) is a highly specialized reproductive medicine and IVF clinic located in Chania, on the island of Crete, Greece. Established in May 1994, the center has grown to become the leading institution for assisted reproductive technologies (ART) and genetic services in Crete, helping thousands of couples from across Greece and internationally achieve successful pregnancies over more than three decades of continuous operation.

The center was founded by its clinical director, Dr. Yannis Giakoumakis MD (Obs/Gyne), who has dedicated his career to advancing reproductive medicine in the eastern Mediterranean region. The expert team includes Dr. Moncef Benkhalifa PhD as Scientific Director (ART and Genetics), Monica Tsouroupaki as ART Laboratory Director and embryologist, and Danae Stamboulis-Abazis as Genetics Laboratory Director and cytogeneticist. This dedicated multidisciplinary team combines clinical, laboratory, and genetic expertise under one roof — a significant advantage for patients with complex fertility or genetic challenges.

MFCGS is equipped with state-of-the-art reproductive technology and ART laboratory facilities maintained to international clinical standards. The center offers a full spectrum of investigations and treatments for infertility, including standard and advanced IVF protocols, ICSI, egg donation cycles, embryo cryopreservation by vitrification, and preimplantation genetic testing (PGT). The integrated genetics laboratory provides cytogenetic analysis and genetic counselling alongside clinical fertility care.

Greece's regulatory framework for IVF and anonymous egg donation is among the most permissive in Europe, enabling cycles that patients from more restrictive countries (Germany, Switzerland, Italy, France) cannot access at home. MFCGS's location in Chania combines clinical excellence with the natural beauty of Crete, making it an appealing destination for patients from the UK, Northern Europe, and the Middle East who seek fertility treatment in a restorative environment.

MFCGS provides a comprehensive range of diagnostic and treatment services for individuals and couples experiencing infertility. Core ART procedures include in vitro fertilization (IVF) using standard controlled ovarian stimulation protocols as well as natural cycle and modified natural cycle IVF for appropriate candidates. Intracytoplasmic sperm injection (ICSI) is performed for male factor infertility, low sperm count, motility, or morphology issues, and for cases of previous fertilization failure.

The center is particularly known for its egg donation program, offering anonymous donor egg IVF cycles for women with diminished ovarian reserve, premature ovarian insufficiency, advanced maternal age, or prior IVF failure. Tandem cycles combining the patient's own eggs with donor eggs are available. Sperm donation, embryo donation, and intrauterine insemination (IUI) with partner or donor sperm are also offered.

Genetic services are a distinct clinical strength of MFCGS. The integrated cytogenetics and molecular genetics laboratory performs preimplantation genetic testing for aneuploidies (PGT-A) and monogenic disorders (PGT-M), enabling selection of chromosomally normal embryos prior to transfer and reducing miscarriage rates. Karyotyping for patients with recurrent pregnancy loss is provided on-site.

Gynecological diagnostics and surgical fertility interventions offered include hysteroscopy (office and operative), laparoscopy, salpingostomy, adhesiolysis, and falloscopy. PCOS diagnosis and management, endometrial biopsy, hysterosalpingography (HSG), and ultrasound with HyCoSy for tubal patency assessment complete the diagnostic portfolio. Additional services include mammography, cervical smears, and andrology assessments.

MFCGS operates a purpose-built, state-of-the-art ART laboratory in Chania. The IVF laboratory is equipped with modern tri-gas incubators maintaining precise temperature, CO2, nitrogen, and oxygen conditions to optimize embryo culture outcomes. A dedicated clean room environment with HEPA air filtration systems is maintained for gamete and embryo handling. Cryopreservation is performed using vitrification — the gold-standard rapid-freezing technique — for embryos, eggs, and sperm, with high post-thaw survival rates.

Micromanipulation equipment supports ICSI procedures, assisted hatching, and embryo biopsy for PGT. The adjacent genetics laboratory is equipped for cytogenetic analysis, FISH (fluorescence in situ hybridization), and next-generation sequencing (NGS) platforms for comprehensive PGT-A and PGT-M testing. The scientific team follows ESHRE (European Society of Human Reproduction and Embryology) guidelines for laboratory quality management.

Clinical facilities include dedicated ultrasound rooms with high-resolution transvaginal ultrasound for follicle monitoring during stimulation cycles, separate consultation suites, and procedure rooms for egg collection under light sedation and for embryo transfer. A comfortable recovery area is available for patients following egg collection procedures.

The center is located at 24 Zimvrakakidon Street in Chania city, with easy access to local accommodation, the Old Town, and the port. Chania International Airport (CHQ) serves the center with seasonal direct flights from the UK, Germany, Netherlands, and Scandinavia, and year-round connections via Athens Airport.

MFCGS has an established tradition of welcoming international patients seeking IVF and reproductive medicine in Crete. Greece is one of Europe's most attractive countries for fertility treatment abroad, particularly for anonymous egg donation — fully legal and well-regulated under Greek Law 3305/2005 — which draws patients from countries including Germany, Switzerland, Italy, and France where anonymous donation is prohibited.

The clinical and administrative team are English-speaking, with the scientific director Dr. Benkhalifa also able to communicate in French. This enables comfortable consultations for patients from the UK, Ireland, France, and other English- and French-speaking countries. The center provides detailed treatment protocols, medication guidance, and follow-up instructions in English.

For international patients, the center offers remote pre-cycle consultations to review medical history, hormone results, and ultrasound reports before travel is arranged. Where clinically feasible, the initial monitoring phase of stimulation can be conducted with a local specialist in the patient's home country before the patient travels to Chania for egg collection and embryo transfer. This minimizes the total time needed on the island to approximately 10–14 days for a standard egg donation cycle.

MFCGS can recommend accommodation options in Chania suited to the duration of the treatment cycle. The clinic's patient coordinators are available to answer queries via email and telephone throughout the treatment process, both before travel and after the patient returns home. Post-treatment follow-up, including pregnancy blood tests and early pregnancy ultrasound interpretation guidance, is provided remotely where possible.

MFCGS operates under the regulatory oversight of the Hellenic National Authority for Medically Assisted Reproduction (EAIVF — Εθνική Αρχή Ιατρικώς Υποβοηθούμενης Αναπαραγωγής), the statutory licensing and supervisory body for all ART clinics in Greece. All fertility treatments, egg donation cycles, and genetic services provided by MFCGS are delivered within the legal framework established by Greek Law 3305/2005 on medically assisted reproduction, which sets binding standards for laboratory quality, informed consent, donor anonymity, embryo handling, and maximum embryo transfer numbers.

The center's ART laboratory adheres to ESHRE (European Society of Human Reproduction and Embryology) clinical and laboratory practice guidelines, which represent the European gold standard for embryology laboratory management, quality control, and outcome reporting. The genetics laboratory complies with ISO standards and best-practice guidelines applicable to cytogenetics and molecular diagnostic services.

Dr. Yannis Giakoumakis and the scientific team maintain active membership in ESHRE and the Hellenic Society of Obstetrics and Gynaecology, ensuring ongoing professional development and alignment with evolving evidence-based standards. The center participates in scientific publications and conference presentations in reproductive medicine and genetics, reflecting its three-decade commitment to evidence-based practice and continuous quality improvement.